Nordic Capital posts millions of euros in Leo Pharma – gets owner's share at under 25 percent

The private equity firm Nordic Capital posts EUR 450m in Leo Pharma and gets an owner's share of under 25 percent in the company. The money will go towards supporting the firm's 2030 strategy, while the notion of getting listed is on the table as a possible exit strategy for Nordic Capital in the long term.
Leo Foundation CEO Jesper Mailind | Photo: Leo Fondet / PR
Leo Foundation CEO Jesper Mailind | Photo: Leo Fondet / PR
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN

After having been the sole owner of Leo Pharma for 35 years, the Leo Foundation now invites one of the Nordics' largest capital funds, Nordic Capital, into the owner group of Denmark's oldest pharmaceutical company.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading